Name: Dyne Therapeutics, Inc. (DYN) Financial Statements
Creator: FinSpry

Dyne Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Dyne Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	2.24	0.00	0.00	0.00	0.00
Gross Profit	-2.24	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	281.41	210.76	142.76	121.31	45.20
Selling, General & Administrative	62.48	31.40	28.20	28.72	13.45
Operating Expenses	343.89	242.16	170.96	150.03	58.65
Operating Income	-343.89	-242.16	-170.96	-150.03	-58.65
Other Income/Expense
Interest Income	26.92	7.64	2.92	0.74	0.06
Interest Expense	0.00	0.00	0.00	0.00	-0.40
Other Income/Expense	26.47	20.42	-0.05	-0.01	-0.45
Income
Income Before Tax	-317.42	-235.94	-168.10	-149.29	-59.44
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-317.42	-235.94	-168.10	-149.29	-59.44
Net Income - Continuous Operations	-317.42	-235.94	-168.10	-149.29	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-342.21	-235.34	-169.28	-148.94	-57.95
EBIT	-343.89	-235.94	-170.96	-150.03	-58.65
Depreciation & Amortization	1.67	1.70	1.68	1.09	0.70
Earnings Per Share
Basic EPS	-3.00	-4.00	-3.00	-3.00	-4.00
Diluted EPS	-3.00	-4.00	-3.00	-3.00	-4.00
Basic Shares Outstanding	94.14	59.68	51.98	50.90	14.40
Diluted Shares Outstanding	94.14	59.68	51.98	50.90	14.40